Mesoblast | MSB - Operating Expenses

Stock Price
2.47
Daily Change
-0.02 -0.80%
Monthly
-10.51%
Yearly
-18.21%
Q1 Forecast
2.48

Mesoblast reported $56.15M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Avita Medical AUD 29.57M 1.21M Jun/2025
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Cochlear AUD 460.1M 437.1M Jun/2025
CSL USD 2.87B 2.85B Jun/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
PYC Therapeutics AUD 19.3M 19.28M Jun/2025
Ramsay Health Care AUD 8.72B 369.4M Jun/2025
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Starpharma Holdings AUD 4.01M 3.81M Jun/2025
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024